Top three stocks that saw heavy demand from buyers in the pre-opening session today
These three stocks were the top gainers on BSE in the pre-opening session today.
At the pre-opening bell, the frontline index S&P BSE Sensex opened in green with a gain of 211.28 points or 0.27 per cent. By 9.17 am, the index stood at 78,394.70, signifying a gain of 123.42 points or 0.16 per cent over its previous closing.
DSIJ's 'Large Rhino' service recommends blue chip stocks of Large Cap companies that have leadership positions in their category. If this interests you, do download the service details here.
On the sectoral front, in the pre-opening session, metals jumped by 0.07 per cent, power zoomed by 0.19 and auto soared by 0.24 per cent.
Meanwhile, Aarti Pharmalabs Ltd, Ideaforge Technology Ltd, and Godrej Industries Ltd emerged as the Top Gainers of BSE in the pre-opening session today.
Aarti Pharmalabs Ltd rallied 16.3 per cent to trade at Rs 741.50 apiece. The company has announced an Interim dividend of Rs 2.5 per equity share (50 per cent of the face value of Rs 5) for the financial year 2024-25. The Record Date for the dividend payment is set for Friday, February 14, 2025. Additionally, the company has released its financial results for the third quarter ended December 31, 2024.
Ideaforge Technology Ltd, an S&P BSE company, surged 6.04 per cent to trade at Rs 488.60 apiece. The Madras High Court has dismissed the quashing petition (CRL MP 5163/2024) against the Final Report in CC No. 1344/2024 (formerly CC No. 6907/23). The company, in consultation with its legal advisors, will decide on the next steps after reviewing the court’s order.
Godrej Industries Ltd an S&P BSE company, climbed 5.69 per cent to trade at Rs 933.95 apiece. The company announced that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2024, after these results are reviewed by the Audit Committee.
Disclaimer: The article is for informational purposes only and not investment advice.